The FDA said it would delay feedback on a diabetes drug developed by Lexicon previously expected by the end of the month, saying it needed more time to review data Lexicon submitted.

People who use cannabis are four times more likely to develop type 2 diabetes than people who do not use it, a new study has ...

Introduction With the COVID-19 pandemic driving people into social isolation, causing a financial crisis and creating uncertainty, individuals were at an even greater risk of experiencing negative ...

There’s a good chance that you haven’t heard about a rare condition called chromhidrosis. In a nutshell, the person afflicted with the disease produces colored sweat, from yellow to green, even red ...

The importance of psychological distress in patients with cardiovascular disease is increasingly recognized as both a contributing factor to the development and progression of cardiovascular disease ...

Most consumers consider yogurt a nutritious food because it is a cultured dairy product that contains live and active cultures.

The prizewinning novelist’s unsparing memoir, “Mother Mary Comes to Me,” captures the eventful life and times of her mother, a driven educator and imperfect inspiration. Arundhati Roy with her brother ...

Background: Heart failure (HF) is a major public health concern in Bangladesh, responsible for approximately 0.1 million deaths annually and accounting for 15.23% of tot ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have rapidly emerged as highly effective pharmacological tools for weight management, with additional cardiometabolic benefits extending beyond ...

Last week, a study involving more than nine million pregnancies reported that children whose mothers had gestational diabetes ...

Diabetes insipidus is very different from diabetes mellitus. It has nothing to do with blood sugar. Instead, the problem is with a hormone called arginine vasopressin (AVP), also known as ...

Researchers writing in The Lancet review breakthroughs in type 1 diabetes treatment, from immunotherapies that delay onset to ...